Physician profile
Dode N Washington
NPI 1366591109
$425.40
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $61.38 · 2021: $174.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $140.79 | 2019-2021 | |
| Boston Scientific Corporation | $85.15 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.09 | 2019-2020 | |
| Avion Pharmaceuticals | $30.69 | 2021 | |
| Amag Pharmaceuticals, INC. | $23.48 | 2019 | |
| Hologic Sales and Service, LLC | $22.65 | 2019 | |
| Allergan, INC. | $21.83 | 2019 | |
| Duchesnay USA Incorporated | $16.93 | 2019 | |
| Exeltis, USA INC. | $15.07 | 2021 | |
| Lupin INC. | $12.72 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dode Washington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.